30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
Condition(s):Dyslipidemia; Kidney DiseaseLast Updated:October 3, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Dyslipidemia; Kidney DiseaseLast Updated:October 3, 2012Completed
Condition(s):PharmacokineticsLast Updated:October 19, 2010Completed
Condition(s):Coronary Artery Disease; Coronary Heart Disease; DyslipidemiaLast Updated:July 2, 2018Completed
Condition(s):HealthyLast Updated:September 28, 2012Completed
Condition(s):Hypercholesterolemia; DyslipidemiaLast Updated:October 3, 2012Completed
Condition(s):HealthyLast Updated:September 28, 2012Completed
Condition(s):HealthyLast Updated:September 28, 2012Completed
Condition(s):Dyslipidemia; Atherosclerosis; Diabetes Mellitus, Type 2Last Updated:October 4, 2022Recruiting
Condition(s):Dyslipidemia; Coronary Heart Disease; Mixed DyslipidemiaLast Updated:July 23, 2009Completed
Condition(s):Dyslipidemia; Coronary Heart Disease; Mixed DyslipidemiaLast Updated:June 10, 2009Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.